EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news
Issue link: https://daily.eyeworld.org/i/308364
EW SHOW DAILY 67 T erry Kim, MD, will moder- ate a unique CME sympo- sium today on the more significant barriers to suc- cess with refractive IOL cataract surgery. To date we have improved refractive IOL outcomes through various means such as proper patient selection, improved biometry, OCT and keratometry technology, new refractive IOL de- signs, and femtosecond technology for advanced corneal and lenticular surgery. However, one of the most signif- icant variables with refractive IOL outcomes remains a challenge. This is the impact of postoperative inflammation on the premium out- comes that we are expecting from refractive IOL surgery. Important factors in the dosing, molecular design, formulation and vehicle of the therapy all impact surgeons' ability to mitigate and even prevent postoperative inflammation in the cataract patient. This program, titled "Knocking Down Inflammatory Barriers to Suc- cess in Refractive Cataract Surgery," will involve the following lectures and a related panel discussion on the reviewed topics: • Keith A. Warren, MD: "Impact of Inflammation on the Posterior Segment and Role of Anti-Inflam- matory Therapy Following Refrac- tive Cataract Surgery." This topic will include discussion of CME and variability in visual acuity and quality of results and key weapons to eliminate posterior segment inflammation. • Uday Devgan, MD: "Impact of Inflammation on the Anterior Seg- ment and Role of Anti-Inflamma- tory Therapy Following Refractive Cataract Surgery." This topic will include discussion on how to "Increase Understanding that Anti-Inflammatory Therapy is One of the Last Variables in Successful Refractive Cataract Surgery." • David F. Chang, MD: A review of an important new study on "Risk Factors for Steroid Response Among Cataract Patients." by Maximizing Concentrations of Anti-Inflammatory Therapy in the Target Tissue." This topic will in- clude discussion of "Viscosity and Other Key Considerations in Selecting the Appropriate Formu- lation." Exciting data is already rolling in from a survey conducted a few days ago with all ASCRS members who have preregistered for this sym- posium. So far, more than 75% of survey respondents state that their visual acuity and quality results, vi- sual recovery times, and patient sat- isfaction in refractive IOL patients are significantly impacted by low-to- moderate ocular inflammation. Another survey question in- volves whether steroids and NSAIDs are used both pre- and postop. While 53% are using both routinely February 2011 ASCRS SYMPOSIUM, SAN DIEGO 2011 Featured symposium: Resolving one of the last barriers to success with refractive IOLs by Brad Fundingsland EyeWorld Educational Development Group Eyemaginations launches a new cloud- based solution for patient education E yemaginations (Baltimore) announced the launch of a new cloud-based software solution. ECHO is a simple, turn-key solu- tion that allows healthcare professionals to communicate with patients from any internet-based device such as a tablet, PC, or smartphone. Combining the full list of Eyemaginations content into one centralized library, ECHO provides doctors with a way to market their practices effectively with minimal investment and time spent. "The ECHO platform makes it easy for our clients to communicate with patients effectively and efficiently from anywhere. We are commit- ted to continuous innovation," said Jeff Peres, president and CEO of Eyemaginations. ECHO is designed to help healthcare professionals communicate with their patients everywhere they are thinking about their health, in- cluding before the appointment, in the waiting room, in the exam room, and after the appointment. From one central location, users can share preferred content from a variety of ready-made presentations on specific topics or they can build their own presentations. A unique new reporting feature allows the user to then monitor the success of each presentation by tracking patients' viewing habits. With a vast library of even more new peer-reviewed medical con- tent, ECHO also offers full integration with various social media plat- forms as well as high compatibility with any popular and internet-based device. ECHO has flexible subscription levels that will work for any size practice. Those interested in learning more about ECHO can register online to request a free demo by visiting the Eyemaginations website on the Take a Demo page or by visiting booth #1102. EW Breaking news • Francis S. Mah, MD: "Strategies to Prevent Edema and Relieve Pain tion and visual acuity/quality – Steve Schallhorn, MD • Strategies for addressing pre-exist- ing astigmatism – Warren Hill, MD • How do you get started with AI/LRIs? – Bill Trattler, MD • What levels of refractive error can we treat with today's LVC technol- ogy – Steve Schallhorn, MD • How do you get started with performing PRK? • Preoperative steps – Sonia Yoo, MD • Surgical steps, postop care and complication management – Karl Stonecipher, MD • Panel discussion: Identify the means to overcome key clinical and technology access barriers to laser vision correction in postoper- ative refractive IOL patients – Richard Lindstrom, MD, John Vukich, MD This CME symposium will take place in the Moscone Center, EyeWorld Theater (Gateway Ballroom), which is just across the hallway from the Exhibit Hall, on Monday morning, with a 6:00 a.m. registration and breakfast, and a 6:30 a.m. start time for the one-hour symposium. This program is supported by an unrestricted grant from Abbott Medical Optics (Santa Ana, Calif.) and Alcon (Fort Worth, Texas). Onsite registration is avail- able. EW continued from page 66 continued on page 68